Correlative serum biomarker analyses in the phase 2 trial of lenvatinib-plus-everolimus in patients with metastatic renal cell carcinoma
British Journal of Cancer, Published online: 07 October 2020; doi:10.1038/s41416-020-01092-0Correlative serum biomarker analyses in the phase 2 trial of lenvatinib-plus-everolimus in patients with metastatic renal cell carcinoma
Source: British Journal of Cancer - Category: Cancer & Oncology Authors: Chung-Han Lee Robert J. Motzer Hilary Glen M. D. Michaelson James Larkin Yukinori Minoshima Michio Kanekiyo Hiroki Ikezawa Pallavi Sachdev Corina E. Dutcus Yasuhiro Funahashi Martin H. Voss Source Type: research
More News: Cancer | Cancer & Oncology | Carcinoma | Kidney Cancer | Renal Cell Carcinoma | UK Health